News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
FDA Again Warns Apotex Corp., a Generic Maker, About Conditions at Its Plants
April 16, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NY Times -- Federal regulators have raised another red flag about the quality of generic drugs, sending a warning letter to a leading maker about manufacturing violations.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Drug pricing
Trump Taps Oz To Lead Drug Pricing Negotiations as Customs Warns Against Import Violations
May 27, 2025
·
2 min read
·
Tristan Manalac
FDA
‘Make American Healthy Again’ Report Takes Aim at Pharma Lobbying, GLP-1s and Vaccines
May 23, 2025
·
4 min read
·
Annalee Armstrong
Government
Court Halts HHS’ Reduction and Layoff Plans, Arguing a Lack of Authority
May 23, 2025
·
2 min read
·
Dan Samorodnitsky
Government
Changes to IRA Pill Penalty Conspicuously Absent as Congress Narrowly Passes Trump’s Tax Bill
May 23, 2025
·
2 min read
·
Tristan Manalac
